ARCHIVES

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

This article is from The Cancer Letter archive.

Vol. 31 No. 38 | October 21, 2005

Download PDF Visit The Full Archive

Related Articles

BCDDP “Major Accomplishment” Described By ACS’ Holleb

July 21, 1978

Senate Votes Down Attempt to Cut NCI Funds $100 Million

October 3, 1975

GAO Eppley Report Offers Lessons for Grantees, Contractors

March 3, 1978

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996

CSR Draft Report Proposes New Panel To Review Clinical Oncology Research

February 20, 1998

President Proposes 2.1% Incerase for NIH, 2.4% Increase for NCI, In Year 2000 Budget

February 5, 1999